Poor prognosis in patients with steroid refractory acute graft versus host disease treated with etanercept: a multi-centre analysis

Bone Marrow Transplant. 2018 Nov;53(11):1478-1482. doi: 10.1038/s41409-018-0215-4. Epub 2018 May 24.
No abstract available

Publication types

  • Letter
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Etanercept / pharmacology
  • Etanercept / therapeutic use*
  • Female
  • Graft vs Host Disease / drug therapy*
  • Graft vs Host Disease / pathology
  • Humans
  • Immunosuppressive Agents / pharmacology
  • Immunosuppressive Agents / therapeutic use*
  • Male
  • Middle Aged
  • Prognosis

Substances

  • Immunosuppressive Agents
  • Etanercept